Blue Cross Blue Shield Association Tentative $2.67 Billion Antitrust Settlement - Bim Group

Blue Cross Blue Shield Association Tentative $2.67 Billion Antitrust Settlement


Disclaimer: The following is provided for informational only purposes. As a reminder, the lawsuit and subsequent settlement are not specific to one market or association. They are spread across the Blue Cross Blue Shield Association of companies, which is a national federation of 36 independent, community-based, and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage.  If you have any questions or concerns, please feel free to contact your account management team at Bim Group.

Blue Cross Blue Shield Association (BCBSA) has been involved in a class-action lawsuit for more than eight years. Per the article below, the lawsuit is across states and commercial health products under the BCBSA organization. The pending settlement will not be finalized until sometime in early 2021. The important take away is the settlement means subscribers will have more choices for health insurance, which should result in more favorable pricing. After the settlement is approved and the Court finalizes, a settlement administrator will proceed with distributing payments. Payments, which the amount is unknown at this time, will be sent to eligible class members as approved by the Court.

Blue Cross Blue Shield Association Tentative $2.67 Billion Antitrust Settlement

Blue Cross Blue Shield Association (BCBSA) has recently reached a tentative $2.67 billion settlement arising out of a class action lawsuit filed more than eight years ago by subscribers seeking injunctive and compensatory relief arising out of BCBSA’s alleged violation of federal antitrust laws. The settlement will result in the dismissal of the case and a finding of no liability against BCBSA for the subscriber’s claims, which BCBSA continues to reject in their statement regarding the litigation.

Alleged Violations

The subscribers alleged that BCBSA violated several provisions of the Sherman Antitrust Act, which is a federal law prohibiting interference with trade and competition, by entering into an unlawful agreement that interfered with competition in the health insurance market by: (1) allocating geographic territories among members of the Blues association, thereby limiting subscriber choice; (2) limiting Blue member plans from competing against each other, even when not using a Blue by name, by mandating a minimum percentage of business that each member plan must perform under that name, both inside and outside each Blue member plan’s territory; (3) restricting the right of any Blue member plan to be sold to a company that is not a member of BCBSA; and (4) agreeing to other ancillary restraints on competition.

The subscribers alleged that the overall impact of the BCBSA’s conduct was the limitation on subscriber health insurance options and pricing. The subscribers alleged that they paid inflated premiums as a result of the Blues’ anti-competitive practices and sought monetary and injunctive relief.


After nearly five years of negotiations, the parties have agreed to a proposed settlement with the monetary value of $2.67 billion payable to qualifying policyholders and employees of insured groups and self-funded accounts covered by a Blue-branded commercial health benefit product. These products include, but are not limited to, medical, pharmacy, dental and vision services, regardless of whether the individual contributed to the cost of coverage. Individuals covered by a stand-alone vision or dental product are not covered by the settlement, nor are beneficiaries and dependents. The settlement agreement apportions the settlement fund distributions between employers and covered employees when both parties make a claim.

The settlement also includes the following historic injunctive relief designed to enhance competition in the health insurance market.

  • The elimination of the Blues’ national revenue cap on competition when they are not using the Blue names and marks, which will allow Blue plans to compete against other Blue plans when the coverage is not sold under the Blues umbrella.
  • The ability for certain qualified national accounts, which are employers that offer the same benefits coverage across multiple sites, who could previously only seek one Blue bid, to seek an additional national bid from a Blue plan.
  • Limits on BCBSA’s restraints on acquisitions.
  • New guidelines to permit direct contracting between non-provider vendors and self-funded accounts.

Compliance with the injunctive relief will also be accompanied by a five-year monitoring period by the court and a committee formed for this purpose.


The impact of the settlement is intended to increase competition by providing subscribers with more choices and result in more favorable pricing.

Recent Insights

January 4, 2021

New York Life’s Acquisition of CIGNA Group Insurance is Complete

The New York Life acquisition of Cigna Group Insurance (CGI) is complete and Cigna Group Insurance is now New York Life Group Benefit Solutions. The full transition to New York Life will take several months. Your CIGNA service team is not changing and at this time there are no changes to your service sites, customer […]
Read more
December 30, 2020

Happy Holidays from Bim Group!

Thank you for the confidence and trust your company has placed in Bim Group to manage your employee benefit plan throughout this challenging and at times uncertain year. As we reflect on the privilege to serve our clients, we are honored to contribute to the following organizations that make a meaningful difference in the lives […]
Read more
December 28, 2020
Compliance Alert, COVID 19, Webinar

Webinar: COVID-19 Compliance Considerations for Group Health Plans in 2021

Tuesday, January 12, 2021 2:00 p.m. ET / 11:00 a.m. PT Register Now Due to the COVID-19 pandemic, Congress has issued legislation affecting group health plan requirements and the Department of Labor (DOL), Department of Health and Human Services (HHS), and Internal Revenue Service (IRS) have issued guidance on requirements for group health plans as […]
Read more
December 16, 2020
Affordable Care Act (PPACA), CMS, Compliance Alert

Proposed 2022 Benefit Payment and Parameters Rule

( 3 MINUTE READ ) The Centers for Medicare & Medicaid Services (CMS) has released a proposed rule and fact sheet for benefit payment and parameters for 2022. CMS has also released its draft 2022 actuarial value calculator and draft 2022 actuarial value calculator methodology. According to CMS, the proposed rule is intended to reduce […]
Read more